Abstract
We carried out a model of chronic inflammation using a subcutaneous paraffin tablet in mice experimentally infected with Leishmania major. It was previously reported that the parasite load following paraffin implantation occurred at a peak of 21 days in both BALB/c and C57BL/6 mice. At the present study, we have investigated what cytokines and chemokines are directly related to the parasite load in C57BL/6 mice. All mice were divided in four groups: mice implanted with paraffin tablets; mice experimentally infected with L. major; mice implanted with paraffin tablets and experimentally infected with L. major; and mice submitted only to the surgery were used for the Real-Time Polymerase Chain Reaction (RT-PCR) controls. Fragments of skin tissue and the tissue surrounding the paraffin tablets (inflammatory capsule) were collected for histopathology and RT-PCR studies. By 21 days, a diffuse chronic inflammatory reaction was mainly observed in the deep dermis where macrophages parasitized with Leishmania amastigotes were also found. RT-PCR analysis has shown that BALB/c mice showed strong IL-4 and IL-10 mRNA expression than controls with very little expression of IFN-γ. In contrast, both IFN-γ and IL-10 mRNA was found in higher levels in C57BL/6 animals. Moreover, in C57BL/6 mice the expression of chemokines mRNA of CCL3/MIP-1α was more highly expressed than CCL2/MCP-1. We conclude that the Th1 immune response C57BL/6 did not change to a Th2 response, even though C57BL/6 animals presented higher parasitism than BALB/c mice 21 days after infection and paraffin implantation.
Similar content being viewed by others
References
Alexander J, Russell DG (1992) The interaction of Leishmania species with macrophages. Adv Parasitol 31:175–254. doi:10.1016/S1471-4922(02)02352-8
Bogdan C, Donhauser N, Döring R, Röllinghoff M, Diefenbach A, Rittig MG (2000) Fibroblasts as host cells in latent leishmaniosis. J Exp Med 191:2121–2130. doi:10.1016/j.ijid.2008.11.008
Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Rollinghoff M, Gresser I, Bogdan C (1998) Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity 8:77–87. doi:10.1016/S1074-7613(00)80460-4
Bogdan C, Rollinghoff M (1998) The immune response to Leishmania: mechanisms of parasite control and evasion. Int J Parasitol 28:121–134. doi:10.1016/S0020-7519(97)00169-0
Vester B, Muller K, Solbach W, Laskay T (1999) Early gene expression of NK cell-activating chemokines in mice resistant to Leishmania major. Infect Immun 67:3155–3159
Moll H (2000) The role of dendritic cells at the early stages of Leishmania infection. Adv Exp Med Biol 479:163–173. doi:10.1007/0-306-46831-X_14
Von Stebut E, Belkaid Y, Jakob T, Sacks DL, Udey MC (1998) Uptake of Leishmania major amastigotes results in activation and interleukin 12 release from murine skin-derived dendritic cells: implications for the initiation of anti-Leishmania immunity. J Exp Med 188:1547–1552
Liew FY, Li Y, Millott S (1990) Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide. J Immunol 145:4306–4310
Ritter U, Korner H (2002) Divergent expression of inflammatory dermal chemokines in cutaneous leishmaniasis. Parasite Immunol 24:295–301
Ashford RW (2000) The leishmaniases as emerging and reemerging zoonoses. Int J Parasitol 30:1269–1281. doi:10.1016/S0020-7519(00)00136-3
Silveira FT, Lainson R, Corbett CE (2005) Further observations on clinical, histopathological, and immunological features of borderline disseminated cutaneous leishmaniasis caused by Leishmania (Leishmania) amazonensis. Mem Inst Oswaldo Cruz 100:525–534
Sousa AQ, Pompeu MML, Sólon FRN, Frutuoso MS, Teixeira MJ, Silva TMJ (2006) Disseminated cutaneous leishmaniasis: a patient with 749 lesions. Braz J Infect Dis 10:230–230
Roychoudhury K, Roy S (2004) Role of chemokines in Leishmania infection. Curr Mol Med 4:691–696
Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:243.1–243.10. doi: 10.1186/gb-2006-7-12-243
Scott P (1991) IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J Immunol 147:3149–3155
Gordon S, Taylor PR (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5:953–964. doi:10.1038/nri1733
Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958–969. doi:10.1038/nri2448
Tafuri WL, Melo MN, Paiva MC, Mosser DM, Tafuri WL (2000) Kinetics of an experimental inflammatory reaction induced by Leishmania major during the implantation of paraffin tablets in mice. Virchows Arch 437:429–435. doi:10.1007/s004280000231
Murray HW (1994) Blood monocytes: differing effector role in experimental visceral versus cutaneous leishmaniasis. Parasitol Today 10:220–223. doi:10.1016/0169-4758(94)90117-1
Vieira LQ, Goldschmidt M, Nashleanas M, Pfeffer K, Mak T, Scott P (1996) Mice lacking the TNF receptor p55 fail to resolve lesions caused by infection with Leishmania major, but control parasite replication. J Immunol 157:827–835
Bailey PJ (1988) Sponge implants as models. Methods Enzymol 162:327–334
Yang Z, Mosser DM, Zhang X (2007) Activation of the MAPK, ERK, following Leishmania amazonensis infection of macrophages. J Immunol 178:1077–1085
Sacks D, Noben-Trauth N (2002) The immunology of susceptibility and resistance to Leishmania major in mice. Nat Rev Immunol 2:845–858. doi:10.1038/nri933
Kane MM, Mosser MD (2001) The role of IL-10 in promoting disease progression in leishmaniasis. J Immunol 166:1141–1147
Anderson CF, Oukka M, Kuchroo VJ, Sacks D (2007) CD4(+)CD25(-)Foxp3(-) Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J Exp Med 204:285–297. doi:10.1084/jem.20061886
Anderson CF, Mendez S, Sacks DL (2005) Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice. J Immunol 174:2934–2941
Scharton-Kersten T, Scott P (1995) The role of the innate immune response in Th1 cell development following Leishmania major infection. J Leukoc Biol 57:515–522
Matte C, Olivier M (2002) Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators. J Infect Dis 185:673–681
Barbi J, Ogumu S, Rosas LE, Carlson T, Lu B, Gerard C, Lezama-Davila CM, Satoskar AR (2007) Lack of CXCR3 delays the development of hepatic inflammation but does not impair resistance to Leishmania donovani. J Infect Dis 195:1713–1717
Daly C, Rollins BJ (2003) Monocyte chemoattractant protein-1 (CCL2) in inflammatory disease and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10:247–257
Peters N, Sacks D (2006) Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol Rev 213:159–179. doi:10.1111/j.1600-065X.2006.00432.x
Aliberti J, Reis e Sousa C, Schito M, Hieny S, Wells T, Huffnagle GB, Sher A (2000) CCR5 provides a signal for microbial induced production of IL-12 by CD8 alpha + dendritic cells. Nat Immunol 1:83–87
Santiago HC, Oliveira CF, Santiago L, Ferraz FO, de Souza DG, de-Freitas LA, Afonso LC, Teixeira MM, Gazzinelli RT, Vieira LQ (2004) Involvement of the chemokine RANTES (CCL5) in resistance to experimental infection with Leishmania major. Infect Immun 72:4918–4923. doi:10.1128/IAI.72.8.4918-4923.2004
Murdoch C, Finn A (2000) Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:3032–3043
Sato N, Ahuja SK, Quinones M, Kostecki V, Reddick RL, Melby PC, Kuziel WA, Ahuja SS (2000) CC chemokine receptor (CCR)2 is required for langerhans cell migration and localization of T helper cell type 1 (Th1)-inducing dendritic cells. Absence of CCR2 shifts the Leishmania major-resistant phenotype to a susceptible state dominated by Th2 cytokines, b cell outgrowth, and sustained neutrophilic inflammation. J Exp Med 192:205–218
Conrad SM, Strauss-Ayali D, Field AE, Mack M, Mosser DM (2007) Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages. Infect Immun 75:653–665. doi:10.1128/IAI.01314-06
Ritter U, Moll H (2000) Monocyte chemotactic protein-1 stimulates the killing of Leishmania major by human monocytes, acts synergistically with IFN-gamma and is antagonized by IL-4. Eur J Immunol 30:3111–3120. doi:10.1002/1521-4141(200011)30:11<3111::AID-IMMU3111>3.0.CO;2-O
Brandonisio O, Panaro MA, Fumarola I, Sisto M, Leogrande D, Acquafredda A, Spinelli D, Mitolo V (2002) Macrophage chemotactic protein-1 and macrophage inflammatory protein-1 alpha induce nitric oxide release and enhance parasite killing in Leishmania infantum-infected human macrophages. Clin Exp Med 2:125–129. doi:10.1007/s102380200017
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Letícia Costa Reis, M., Martins Ferreira, V., Zhang, X. et al. Murine immune response induced by Leishmania major during the implantation of paraffin tablets. Virchows Arch 457, 609–618 (2010). https://doi.org/10.1007/s00428-010-0974-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-010-0974-9